Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer

Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation

Ferdinandos Skoulidis, Bob T. Li, Grace K. Dy et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +17

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Archives of Pathology & Laboratory Medicine · 2018 · 931 citations · Full text

Medicine, Oncology, Pathology +17

First-Line Immunotherapy for Non–Small-Cell Lung Cancer

Journal of Clinical Oncology · 2022 · 843 citations

Medicine, Immunology, Oncology +17

Diagnostic value and cost‐effectiveness of on‐site evaluation of fine‐needle aspiration specimens: Review of 5,688 cases

Joseph F. Nasuti, Prabodh K. Gupta, Zubair Baloch · Diagnostic Cytopathology · 2002 · 366 citations

Medicine, Pathology, Cytopathology +13

Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping

Rocco Trisolini, Alessandra Cancellieri, Carmine Tinelli et al. · CHEST Journal · 2015 · 149 citations

Medicine, Oncology, Pulmonology +12